The impact that COVID-19 could have on patients with COPD is a real concern. In this study we evaluated, in a cohort of longitudinally followed COPD subjects, the incidence of COVID-19, seeking for possible risk factors and prognostic factors predicting the clinical outcome. In our cohort of 370 patients (followed for 5.3 ± 2.7 years), 22 developed COVID-19 (COPD/COVID-19+) between February/November 2020 (5.9%). Cardio-metabolic conditions (hypertension, dyslipidemia, obesity, diabetes) but not respiratory abnormalities (FEV1, DLCO, emphysema and exacerbation history), were risk factors for development of COVID-19 in COPD patients. Out of the 22 COPD/COVID-19+ patients, 10 needed intensive care. Low DLCO and emphysema, but also metabolic comorbidities, were related to the need for intensive care.
CITATION STYLE
Bonato, M., Semenzato, U., Tinè, M., Bazzan, E., Damin, M., Biondini, D., … Baraldo, S. (2021). Risk Factors for Development and Severity of COVID-19 in COPD Patients. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.714570
Mendeley helps you to discover research relevant for your work.